From the Safety Assessment and Research Center for Drug, Pesticide, and Veterinary Drug of Jiangsu Province.
the Department of Spine Surgery, Third Affiliated Hospital of Soochow University, Changzhou 213003, China, and.
J Biol Chem. 2018 Jun 29;293(26):10172-10185. doi: 10.1074/jbc.RA117.000327. Epub 2018 May 11.
The formin protein dishevelled-associated activator of morphogenesis 1 (DAAM1) polymerizes straight actin filaments and mediates migration of cancer cells. However, how DAAM1 governs cell haptotaxis in response to collagen remains unexplored in breast cancer cells. We hypothesized that DAAM1 mediates invadopodia extension and cell haptotaxis in response to type IV collagen in association with integrin receptors. Using Boyden chamber membranes coated with type IV collagen, we show here that type IV collagen activates both DAAM1 and Ras homolog family member A (RHOA) and promotes haptotaxis of MDA-MB-231 and MDA-MB-453 breast cancer cells, a process abolished by treatment with the integrin αvβ3 inhibitor cyclo(-RGDfK). shRNA-mediated knockdown of DAAM1 or a dominant-negative DAAM1 mutation (N-DAAM1) significantly decreased collagen-induced RHOA activity and the assembly of stress fibers, invadopodia extension, and cell haptotaxis. Immunoprecipitation and pulldown assays revealed that integrin αvβ3 is associated with, but only indirectly binds to, the C-terminal DAD domain of DAAM1 in mammalian cells. Blockade of RHOA activation with a specific inhibitor (CCG-1423) or via a dominant-negative RHOA mutation (RHOA-N19) suppressed collagen-induced invadopodia extension and haptotaxis of the MDA-MB-231 and MDA-MB-453 cells. Immunoblotting and immunofluorescence assays indicated high DAAM1 and RHOA expression in invadopodia, which was abolished by cyclo(-RGDfK) treatment or DAAM1 knockdown. These findings have uncovered an integrin αvβ3/DAAM1/RHOA signaling pathway for type IV collagen-induced invadopodia extension and haptotaxis in breast cancer cells. Targeting this pathway may be a means for reducing invasiveness and metastasis of breast cancer.
形态发生蛋白卷曲相关激活因子 1(DAAM1)能够聚合直链肌动蛋白丝,并介导癌细胞的迁移。然而,在乳腺癌细胞中,DAAM1 如何控制细胞趋化性以响应胶原蛋白仍未被探索。我们假设,DAAM1 通过与整合素受体结合,介导对 IV 型胶原蛋白的侵袭伪足延伸和细胞趋化性。使用涂覆有 IV 型胶原蛋白的 Boyden 室膜,我们在此表明,IV 型胶原蛋白激活了 DAAM1 和 Ras 同源家族成员 A(RHOA),并促进了 MDA-MB-231 和 MDA-MB-453 乳腺癌细胞的趋化性,该过程被整合素 αvβ3 抑制剂环(-RGDfK)处理所消除。shRNA 介导的 DAAM1 敲低或显性失活 DAAM1 突变(N-DAAM1)显著降低了胶原蛋白诱导的 RHOA 活性和应力纤维、侵袭伪足延伸和细胞趋化性的组装。免疫沉淀和拉下测定显示,整合素 αvβ3 与哺乳动物细胞中的 DAAM1 的 C 端 DAD 结构域相关联,但仅间接结合。用特定抑制剂(CCG-1423)或通过显性失活的 RHOA 突变(RHOA-N19)阻断 RHOA 激活,抑制了 MDA-MB-231 和 MDA-MB-453 细胞中胶原蛋白诱导的侵袭伪足延伸和趋化性。免疫印迹和免疫荧光测定表明,在侵袭伪足中高表达 DAAM1 和 RHOA,这一表达被环(-RGDfK)处理或 DAAM1 敲低所消除。这些发现揭示了一种整合素 αvβ3/DAAM1/RHOA 信号通路,用于 IV 型胶原蛋白诱导的乳腺癌细胞侵袭伪足延伸和趋化性。靶向该通路可能是减少乳腺癌侵袭性和转移的一种手段。